<H1>Chapter DOI: 10.1208/aapsj070482<br/>Cited-By Count: 24</H1><table border="1" width="30%"><tr><td>Total References</td><td>32</td></tr><tr><td>Springer references</td><td>5</td></tr><tr><td>Non Springer references</td><td>27</td></tr><tr><td>BibStructured Count</td><td width="10%">32</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>26</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>1</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Vaccarino AL, Kastin AJ. Endogenous opiates: 2000.<Emphasis Type="Italic">Peptides</Emphasis>. 2001;22:2257&#8211;2328.</td><td><a href=http://dx.doi.org/10.1016/S0196-9781(01)00566-6>10.1016/S0196-9781(01)00566-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Smith QR. A review of blood-brain barrier transport techniques.<Emphasis Type="Italic">Methods Mol Med.</Emphasis> 2003;89:193&#8211;208.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1385/1-59259-419-0:193>10.1385/1-59259-419-0:193</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, FirstPage</td><td>CrossRef</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Banks WA, Kastin AJ. Peptide transport systems for opitates across the blood-brain barrier.<Emphasis Type="Italic">Am J Physiol</Emphasis>. 1990;259:E1-E10.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Kastin AJ, Fasold MB, Smith RR, Horner KA, Zadina JE. Saturable brain-to-blood transport of endomorphins.<Emphasis Type="Italic">Exp Brain Res</Emphasis>. 2001;139:70&#8211;75.</td><td><a href=http://dx.doi.org/10.1007/s002210100736>10.1007/s002210100736</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Somogyvari-Vigh A, Kastin AJ, Liao J, Zadina JE, Pan W. Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells.<Emphasis Type="Italic">Exp Brain Res</Emphasis>. 2004;156:224&#8211;230.</td><td><a href=http://dx.doi.org/10.1007/s00221-003-1774-0>10.1007/s00221-003-1774-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Fiori A, Cardelli P, Negri L, Savi MR, Strom R, Erspamer V. Deltorphin transport across the blood-brain barrier.<Emphasis Type="Italic">Proc. Natl Acad Sci USA</Emphasis>. 1997;94:9469&#8211;9474.</td><td><a href=http://dx.doi.org/10.1073/pnas.94.17.9469>10.1073/pnas.94.17.9469</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Hu H, Miyauchi S, Bridges CC, Smith SB, Ganapathy V. Identification of a novel Na<Superscript>+</Superscript>-and Cl<Superscript>&#8211;</Superscript>-coupled transport system for endogenous opioid peptides in retinal pigment epithelium and induction of the transport system by HIV-1 Tat.<Emphasis Type="Italic">Biochem J</Emphasis>. 2003;375:17&#8211;22.</td><td><a href=http://dx.doi.org/10.1042/BJ20031059>10.1042/BJ20031059</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Leibach FH, Ganapathy V. Peptide transporters in the intestine and the kidney<Emphasis Type="Italic">Annu Rev Nutr</Emphasis>. 1996;16:99&#8211;119.</td><td><a href=http://dx.doi.org/10.1146/annurev.nu.16.070196.000531>10.1146/annurev.nu.16.070196.000531</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Zhao K, Luo G, Zhao GM, Schiller PW, Szeto HH. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2003;304:425&#8211;432.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.040147>10.1124/jpet.102.040147</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Fujita T, Kishida T, Okada N, Ganapathy V, Leibach FH, Yamamoto A. Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implications of high affinity type H+/peptide transporter PEPT2-mediated transport system.<Emphasis Type="Italic">Neurosci. Lett</Emphasis>. 1999;271:117&#8211;120.</td><td><a href=http://dx.doi.org/10.1016/S0304-3940(99)00540-6>10.1016/S0304-3940(99)00540-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Fujita T, Kishida T, Wada M, et al. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2.<Emphasis Type="Italic">Brain Res</Emphasis>. 2004;997:52&#8211;61.</td><td><a href=http://dx.doi.org/10.1016/j.brainres.2003.10.049>10.1016/j.brainres.2003.10.049</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Cordon-Cardo C, O&#8217;Brien JP, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1989;86:695&#8211;698.</td><td><a href=http://dx.doi.org/10.1073/pnas.86.2.695>10.1073/pnas.86.2.695</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Schinkel AH, Wagenaar E, van Deemter L, Mol CA, Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 1995;96:1698&#8211;1705.</td><td><a href=http://dx.doi.org/10.1172/JCI118214>10.1172/JCI118214</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Thompson SJ, Koszdin K, Bernards CM. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein.<Emphasis Type="Italic">Anesthesiology</Emphasis>. 2000;92:1392&#8211;1399.</td><td><a href=http://dx.doi.org/10.1097/00000542-200005000-00030>10.1097/00000542-200005000-00030</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>King M, Su W, Chang A, Zuckerman A, Pasternak GW. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs.<Emphasis Type="Italic">Nat Neurosci</Emphasis>. 2001;4:268&#8211;274.</td><td><a href=http://dx.doi.org/10.1038/85115>10.1038/85115</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Jonker JW, Wagenaar E, van Deemter L, et al Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1999;127:43&#8211;50.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0702497>10.1038/sj.bjp.0702497</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Chen C., Pollack GM. Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-gene-deficient mice.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1998;287:545&#8211;552.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Chen C, Pollack GM. Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulation.<Emphasis Type="Italic">Pharm Res</Emphasis>. 1999;16:296&#8211;301.</td><td><a href=http://dx.doi.org/10.1023/A:1018892811980>10.1023/A:1018892811980</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Sarkadi B, Muller M, Homolya L, et al. Interaction of bioactive hydrophobics peptides with the human multidrug transporter.<Emphasis Type="Italic">FASEB J</Emphasis>. 1994;8:766&#8211;770.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Oude Elferink RPJ, Zadina J. MDR1 P-glycoprotein transports endogenous opioids peptides.<Emphasis Type="Italic">Peptides</Emphasis>. 2001;22:2015&#8211;2020.</td><td><a href=http://dx.doi.org/10.1016/S0196-9781(01)00564-2>10.1016/S0196-9781(01)00564-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Kastin AJ, Fasold MB, Zadina JE. Endomorphins, Met-enkephalin, Tyr-MIF-1, and the P-glycoprotein efflux system.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 2002;30:231&#8211;234.</td><td><a href=http://dx.doi.org/10.1124/dmd.30.3.231>10.1124/dmd.30.3.231</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties.<Emphasis Type="Italic">Pflugers Arch</Emphasis>. 2004;447:653&#8211;665.</td><td><a href=http://dx.doi.org/10.1007/s00424-003-1168-y>10.1007/s00424-003-1168-y</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Cattori V, van Montfoort JE, Stieger B, et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3.<Emphasis Type="Italic">Pflugers Arch</Emphasis>. 2001;443:188&#8211;195.</td><td><a href=http://dx.doi.org/10.1007/s004240100697>10.1007/s004240100697</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A, Meier PJ. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.<Emphasis Type="Italic">J Pharmacol. Exp Ther</Emphasis>. 2000;294:73&#8211;79.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Kullaks-Ublick GA, Ismair MG, Stieger B, et al. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with 3 other OATPs of human liver.<Emphasis Type="Italic">Gastroenterology</Emphasis>. 2001;120:525&#8211;533.</td><td><a href=http://dx.doi.org/10.1053/gast.2001.21176>10.1053/gast.2001.21176</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Nozawa T, Tamai I, Sai Y, Nezu J, Tsuji A. Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin.<Emphasis Type="Italic">J Pharm Pharmacol</Emphasis>. 2003;55:1013&#8211;1020.</td><td><a href=http://dx.doi.org/10.1211/0022357021440>10.1211/0022357021440</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Lee W, Glaeser H, Smith LH, et al. Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2005;280:9610&#8211;9617.</td><td><a href=http://dx.doi.org/10.1074/jbc.M411092200>10.1074/jbc.M411092200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Reichel C, Gao B, Van Montfoort J, et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver.<Emphasis Type="Italic">Gastroenterology</Emphasis>. 1999;117:688&#8211;695.</td><td><a href=http://dx.doi.org/10.1016/S0016-5085(99)70463-4>10.1016/S0016-5085(99)70463-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Konig J, Cui Y, Nies AT, Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 2000;275:23161&#8211;23168.</td><td><a href=http://dx.doi.org/10.1074/jbc.M001448200>10.1074/jbc.M001448200</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Konig J, Cui Y, Nies AT, Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane.<Emphasis Type="Italic">Am J Physiol Gastrointest Liver Physiol</Emphasis>. 2000;278:G156-G164.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Hoffmaster KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 2004;311:1203&#8211;1210.</td><td><a href=http://dx.doi.org/10.1124/jpet.104.070201>10.1124/jpet.104.070201</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Hoffmaster KA, Zamek-Gliszczynski MJ, Pollack GM, Brouwer KL. Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [D-penicillamine2,5] enkephalin.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 2005;33:287&#8211;293.</td><td><a href=http://dx.doi.org/10.1124/dmd.104.001420>10.1124/dmd.104.001420</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>